By Professor Dedee Frances Murrell

Journal articles

Xie D; Bilgic A; Abu Alrub N; Dicle Ö; Murrell DF, 2023, 'Clinical manifestations of alopecia in autoimmune blistering diseases: A cross-sectional study', JAAD International, 10, pp. 6 - 13, http://dx.doi.org/10.1016/j.jdin.2022.08.025

Wilson A; Cowan TL; Rivero ADL; Murrell DF, 2023, 'The dangers of social media: patients with atopic dermatitis ceasing their basic treatment', Clinical and Experimental Dermatology, 48, pp. 142 - 143, http://dx.doi.org/10.1093/ced/llac056

COWAN T; ABU ALRUB N; WİLSON A; MAKHİJA M; MURRELL D, 2023, 'Eksfolyatif keilit tedavisinde tildrakizumab', Mucosa, 6, pp. 19 - 21, http://dx.doi.org/10.33204/mucosa.1209480

Murrell DF; Joly P; Werth VP; Laws E; Mannent LP; Beazley B; Dubost-Brama A; Shabbir A, 2023, '307 The study design of a trial of dupilumab in adult patients with bullous pemphigoid (BP): LIBERTY-BP ADEPT', British Journal of Dermatology, 188, http://dx.doi.org/10.1093/bjd/ljac140.007

Hundt JE; Sadik CD; van Beek N; Busch H; Caux F; Goebeler M; Hammers CM; Hartmann K; Hashimoto T; Ibrahim S; Kasperkiewicz M; Murrell DF; Recke A; Rose C; Schumacher N; Shimanovich I; Sitaru C; Terheyden P; Thaçi D; Ludwig RJ; Schmidt E, 2023, 'A life for autoimmune blistering diseases: in memoriam Detlef Zillikens', Frontiers in Immunology, 14, http://dx.doi.org/10.3389/fimmu.2023.1291590

Koszegi B; Stone C; Murrell DF, 2023, 'Considerations for the use of immunosuppression for the management of pemphigus during the COVID-19 pandemic with a focus on rituximab: Case reports from a single center experience in Australia', Frontiers in Medicine, 10, http://dx.doi.org/10.3389/fmed.2023.1149742

Patsatsi A; Daneshpazhooh M; Tavakolpour S; Mahmoudi H; Murrell DF, 2023, 'Editorial: Challenges of COVID-19 in dermatology patients on immunosuppression: risk, outcome, vaccination and beyond, volume II', Frontiers in Medicine, 10, http://dx.doi.org/10.3389/fmed.2023.1268285

Kern JS; Sprecher E; Fernandez MF; Schauer F; Bodemer C; Cunningham T; Löwe S; Davis C; Sumeray M; Bruckner AL; Murrell DF, 2023, 'Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa: results from the phase III randomized double-blind phase of the EASE study', British Journal of Dermatology, 188, pp. 12 - 21, http://dx.doi.org/10.1093/bjd/ljac001

Rodriguez R; Sivesind TE; Murrell D; Dellavalle RP, 2023, 'From the Cochrane Library: Interventions for Pemphigus Vulgaris and Pemphigus Foliaceus', JMIR Dermatology, 6, http://dx.doi.org/10.2196/46812

Huang C; Bullpitt P; Nabarrro M; Murrell DF, 2023, 'Practice Dilemma: Expanding Melanonychia in the Paediatric Setting', Skin Appendage Disorders, 9, pp. 58 - 60, http://dx.doi.org/10.1159/000526102

Johal J; Cowan T; Bilgic A; Bozca B; Enli S; Yang B; Daneshpazhooh M; Boziou M; Patsatsi A; Mundin C; Quizon M; Kakuta R; Takahashi H; Wilson A; Zeng F; Murrell D, 2023, '390 Examining the risk factors for worsened glucocorticoid morbidity in a prospective, multicentre, international study of patients with autoimmune blistering diseases', Journal of Investigative Dermatology, 143, pp. S67 - S67, http://dx.doi.org/10.1016/j.jid.2023.03.396

Wang MA; Wilson A; Daniel B; Rivero ADL; Martin L; Kern JS; Murrell D, 2023, '396 A novel investigator global assessment score for the evaluation of keratosis pilaris', Journal of Investigative Dermatology, 143, pp. S68 - S68, http://dx.doi.org/10.1016/j.jid.2023.03.402

Tada Y; Takeoka S; Spelman L; Murrell D; Chu C; Chung W; Wu J; Zoob P; Bosman K, 2023, '459 Demographics, comorbidities and disease severity before dupilumab treatment initiation in Asian patients with atopic dermatitis', Journal of Investigative Dermatology, 143, pp. S79 - S79, http://dx.doi.org/10.1016/j.jid.2023.03.465

Joly P; Patel HV; Cella RR; Kephart L; Murrell D, 2023, '639 Design of marigold-bp: A phase 2/3 study of nipocalimab in adults with moderate to severe bullous pemphigoid', Journal of Investigative Dermatology, 143, pp. S109 - S109, http://dx.doi.org/10.1016/j.jid.2023.03.646

Bai H; Lin G; Kantor J; Elston D; Grant-Kels JM; Murrell DF; Murase JE, 2023, 'Dermatology Journal Advisory Boards and Editorial Independence', JAAD International, http://dx.doi.org/10.1016/j.jdin.2023.08.001

Schmidt E; Diaz LA; Amagai M; Murrell DF, 2023, 'Detlef Zillikens, 1958-2022', Journal of Investigative Dermatology, 143, pp. 7 - 8, http://dx.doi.org/10.1016/j.jid.2022.11.001

Keller Rosenthal N; Boucher D; Murrell DF, 2022, 'The efficacy of adding oral sodium cromoglycate to stable treatment for controlling bullous pemphigoid-related pruritus: A retrospective study', Frontiers in Medicine, 9, http://dx.doi.org/10.3389/fmed.2022.1051804

So JY; Fulchand S; Wong CY; Li S; Nazaroff J; Gorell ES; de Souza MP; Murrell DF; Teng JM; Chiou AS; Tang JY, 2022, 'A global, cross-sectional survey of patient-reported outcomes, disease burden, and quality of life in epidermolysis bullosa simplex', Orphanet Journal of Rare Diseases, 17, http://dx.doi.org/10.1186/s13023-022-02433-3

Paller AS; Pope E; Rudin D; Malyala A; Ramsdell D; Johnson R; Landy H; Murrell DF, 2022, 'A prospective short-term study to evaluate methodologies for the assessment of disease extent, impact, and wound evolution in patients with dystrophic epidermolysis bullosa', Orphanet Journal of Rare Diseases, 17, http://dx.doi.org/10.1186/s13023-022-02461-z

Vermeer MCSC; Al-Shinnag M; Silljé HHW; Gaytan AE; Murrell DF; McGaughran J; Melbourne W; Cowan T; van den Akker PC; van Spaendonck-Zwarts KY; van der Meer P; Bolling MC, 2022, 'A translation re-initiation variant in KLHL24 also causes epidermolysis bullosa simplex and dilated cardiomyopathy via intermediate filament degradation', British Journal of Dermatology, 187, pp. 1045 - 1048, http://dx.doi.org/10.1111/bjd.21832

Mazaherpour E; Kianfar N; Dasdar S; Sedaghat M; Seyrafi H; Balighi K; Saberi F; Nili A; Farimani Z; Azar PM; Mahmoodi H; Murrell DF; Daneshpazhooh M, 2022, 'Applicability of glucocorticoid toxicity index in pemphigus: Comparison between two groups of rituximab-treated and rituximab-naïve patients', Dermatologic Therapy, 35, http://dx.doi.org/10.1111/dth.15902

Ho G; Gibson M; Kazemikhoo N; Murrell DF, 2022, 'Long-term follow-up of epidermolysis bullosa in real practice shows stability of the Epidermolysis Bullosa Disease Activity and Scarring Index and improvement with some off-label therapies', JAAD International, 9, pp. 105 - 107, http://dx.doi.org/10.1016/j.jdin.2022.07.008

Lee BWH; Taylor SF; Gal A; Murrell DF; Coroneo MT, 2022, 'Sebaceous cell carcinoma presenting as ocular Marjolin ulcer following immunosuppression for a chemical burn', Canadian Journal of Ophthalmology, 57, pp. e206 - e208, http://dx.doi.org/10.1016/j.jcjo.2022.02.023

Zeng FAP; Wilson A; Sheriff T; Murrell DF, 2022, 'Side effects of steroid-sparing agents in patients with bullous pemphigoid and pemphigus: A systematic review', JAAD International, 9, pp. 33 - 43, http://dx.doi.org/10.1016/j.jdin.2022.07.005

Teng JMC; Bunick CG; Guenthner S; Murrell DF; Marathe K; Kempers S; Eads K; Mendelsohn AM; Raiz J; Tavakkol A; Castelo-Soccio L, 2022, 'The CONTROL study: A randomized, double-blind vehicle-controlled phase 2b study of novel topical isotretinoin formulation demonstrates improvement in recessive X-linked and autosomal recessive lamellar congenital ichthyosis', Journal of the American Academy of Dermatology, 87, pp. 1455 - 1458, http://dx.doi.org/10.1016/j.jaad.2022.07.028

Zeng FAP; Murrell DF, 2022, 'Bullous pemphigoid—What do we know about the most recent therapies?', Frontiers in Medicine, 9, http://dx.doi.org/10.3389/fmed.2022.1057096

Bilgic A; Murrell DF, 2022, 'Designing the Future of Dermatology and Venereology', EMJ Dermatology, pp. 18 - 19, http://dx.doi.org/10.33590/emjdermatol/10176803

Karakioulaki M; Murrell DF; Kyriakou A; Patsatsi A, 2022, 'Investigation of comorbid autoimmune diseases in women with autoimmune bullous diseases: An interplay of autoimmunity and practical implications', International Journal of Women's Dermatology, 8, http://dx.doi.org/10.1097/JW9.0000000000000053

Murrell DF; Patsatsi A; Stavropoulos P; Baum S; Zeeli T; Kern JS; Sinclair R; Neale A; Arora P; Sugerman PB; Shi G; Werth VP; Caux F; Joly P; Patsatsi A; Sinclair R; Neale A; Arora P; Shi G; Werth VP; Caux F; Joly P; Stavropolous P; Baum S, 2022, 'Phase 2 BELIEVE study part B: Efficacy and safety of rilzabrutinib for patients with pemphigus vulgaris', Journal of the European Academy of Dermatology and Venereology, 36, pp. 852 - 855, http://dx.doi.org/10.1111/jdv.18318

Borradori L; Van Beek N; Feliciani C; Tedbirt B; Antiga E; Bergman R; Böckle BC; Caproni M; Caux F; Chandran NS; Cianchini G; Daneshpazhooh M; De D; Didona D; Di Zenzo GM; Dmochowski M; Drenovska K; Ehrchen J; Goebeler M; Groves R; Günther C; Horvath B; Hertl M; Hofmann S; Ioannides D; Itzlinger-Monshi B; Jedličková J; Kowalewski C; Kridin K; Lim YL; Marinovic B; Marzano AV; Mascaro JM; Meijer JM; Murrell D; Patsatsi K; Pincelli C; Prost C; Rappersberger K; Sárdy M; Setterfield J; Shahid M; Sprecher E; Tasanen K; Uzun S; Vassileva S; Vestergaard K; Vorobyev A; Vujic I; Wang G; Wozniak K; Yayli S; Zambruno G; Zillikens D; Schmidt E; Joly P, 2022, 'Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV)', Journal of the European Academy of Dermatology and Venereology, 36, pp. 1689 - 1704, http://dx.doi.org/10.1111/jdv.18220

Hall R; Culton D; Liu Z; Ujiie H; Schmidt E; Murrell D; Stoykov I; Verheesen P; Borradori L; Joly P, 2022, 'ESDR070 - Treating Bullous Pemphigoid by Inhibiting FcRn: A Phase 2/3 Trial with Efgartigimod', , http://dx.doi.org/10.26226/m.62fa009023ef91001a663bab

Wu D; Daniel BS; Lai AJX; Wong N; Lim DKA; Murrell DF; Lim BXH; Mehta JS; Lim CHL, 2022, 'Dupilumab-associated ocular manifestations: A review of clinical presentations and management', Survey of Ophthalmology, 67, pp. 1419 - 1442, http://dx.doi.org/10.1016/j.survophthal.2022.02.002

Ohri S; Sun M; Wilson BN; Murrell DF; Murase JE, 2022, 'Evaluating skin colour representation in the Indian Journal of Dermatology, Venereology and Leprology', Indian Journal of Dermatology, Venereology and Leprology, 88, pp. 678 - 679, http://dx.doi.org/10.25259/IJDVL_947_2021

Mahmoudi H; Patsatsi A; Murrell DF; Tavakolpour S; Daneshpazhooh M, 2022, 'Editorial: Challenges of COVID-19 in dermatology patients on immunosuppression: Risk, outcome, vaccination, and beyond', Frontiers in Medicine, 9, http://dx.doi.org/10.3389/fmed.2022.987534

Cowan TL; Murrell DF; Lara Rivero A, 2022, 'Allergic contact dermatitis to miconazole for nipple candidiasis', Contact dermatitis, 87, pp. 201 - 202, http://dx.doi.org/10.1111/cod.14125

Cowan TL; Wilson A; Murrell DF, 2022, 'Mental health, insomnia and suicidal ideation during treatment with apremilast', Australasian Journal of Dermatology, 63, pp. 403 - 404, http://dx.doi.org/10.1111/ajd.13864

Wi D; Wilson A; Satgé F; Murrell DF, 2022, 'Psoriasis and osteoporosis: a literature review', Clinical and Experimental Dermatology, 47, pp. 1438 - 1445, http://dx.doi.org/10.1111/ced.15174

Foley P; Spelman L; Murrell DF; Mate E; Tronnberg R; Lowe PM, 2022, 'Secukinumab treatment showed improved quality of life in patients with chronic plaque psoriasis in Australia: Results from the HOPE study', Australasian Journal of Dermatology, 63, pp. 312 - 320, http://dx.doi.org/10.1111/ajd.13893

Cowan TL; Makhija M; Murrell DF, 2022, 'Pemphigoid gestationis and preeclampsia in a donor-egg IVF pregnancy', International Journal of Women's Dermatology, 8, http://dx.doi.org/10.1097/JW9.0000000000000026

Guignant M; Tedbirt B; Murrell DF; Amagai M; Aoki V; Bauer J; Ciancinni G; Culton D; Daneshpazhooh M; De D; Fairley J; Hall R; Kim SC; Korman NJ; Kowalewski C; Mimouni D; Patsatsi A; Hebert V; Saleh MAM; Schmidt E; Sprecher E; Uzun S; Venning V; Werth VP; Zillikens D; Joly P, 2022, 'How Do Experts Treat Patients with Bullous Pemphigoid around the World? An International Survey', JID Innovations, 2, http://dx.doi.org/10.1016/j.xjidi.2022.100129

COWAN T; WALLMAN L; MURRELL D, 2022, 'Vaxzevria COVID-19 aşısı sonrasında gelişen şiddetli büllöz pemfigoid', Mucosa, 5, pp. 27 - 29, http://dx.doi.org/10.33204/mucosa.993581

Wilson A; Murrell DF, 2022, 'Clinical features of chronic bullous dermatosis of childhood', Clinical and Experimental Dermatology, 47, pp. 873 - 881, http://dx.doi.org/10.1111/ced.15059

Rathod D; Kroumpouzos G; Lallas A; Rao B; Murrell DF; Apalla Z; Grabbe S; Loquai C; Goldust M, 2022, 'Critical Review of the Sentinel Lymph Node Surgery in Malignant Melanoma', Journal of Drugs in Dermatology, 21, pp. 510 - 516, http://dx.doi.org/10.36849/JDD.6198

Wilson B; Sun M; Chennareddy S; Murrell D; Murase J, 2022, 'An Analysis of Skin of Color Publications in the Journal of Drugs in Dermatology from 2018 to 2020', Journal of drugs in dermatology : JDD, 21, pp. 441 - 442, http://dx.doi.org/10.36849/JDD.6286

Greenblatt DT; Pillay E; Snelson K; Saad R; Torres Pradilla M; Widhiati S; Diem A; Knight C; Thompson K; Azzopardi N; Werkentoft M; Moore Z; Patton D; Mayre-Chilton KM; Murrell DF; Mellerio JE, 2022, 'Recommendations on pregnancy, childbirth and aftercare in epidermolysis bullosa: a consensus-based guideline*', British Journal of Dermatology, 186, pp. 620 - 632, http://dx.doi.org/10.1111/bjd.20809

Behkar A; Garmaroudi G; Nasimi M; Yousefi S; Khosravi H; Kianfar N; Murrell DF; Daneshpazhooh M, 2022, 'Assessing quality of life in patients with autoimmune bullous diseases using the persian version of treatment of autoimmune bullous disease quality of life questionnaire finds similar effects in women as men', International Journal of Women's Dermatology, 8, http://dx.doi.org/10.1097/JW9.0000000000000004

Sun M; Wilson BN; Zhou RZ; Murrell DF; Murase JE, 2022, 'Evaluation of skin of color content in Skin Research and Technology', Skin Research and Technology, 28, pp. 355 - 356, http://dx.doi.org/10.1111/srt.13105

Liang Y; Zeng FAP; Sheriff T; Wilson A; Bilgic A; Feng G; Stone JH; Murrell DF, 2022, 'Evaluation of the toxicity of glucocorticoids in patients with autoimmune blistering disease using the Glucocorticoid Toxicity Index: A cohort study', JAAD International, 6, pp. 68 - 76, http://dx.doi.org/10.1016/j.jdin.2021.09.003

Bishnoi A; Manjunath S; Kishore K; De D; Handa S; Murrell DF; Mahajan R, 2022, 'Hindi translation and validation of quality of life score in Indian patients with epidermolysis bullosa; and its correlation with the clinical severity assessment scores: A cross-sectional study', Indian Journal of Dermatology, Venereology and Leprology, 88, pp. 177 - 183, http://dx.doi.org/10.25259/IJDVL_31_20

Wilson BN; Sun M; Shah R; Murrell DF; Murase JE, 2022, 'Purposeful inclusion of skin of colour in published literature for improved dermatology education: a call to action', Clinical and Experimental Dermatology, 47, pp. 409 - 410, http://dx.doi.org/10.1111/ced.14821

Back to profile page